Friday 6 November 2026 Export GILD’s income statement to Excel — free account

Gilead Sciences, Inc.

GILD Healthcare Drug Manufacturers General

Gilead Sciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $29.4 billion, up 2.40% from fiscal 2024.

Revenue: +6.83%
EPS: −20.3%
Free cash flow: +21.1%
Total debt: +5.17%

Quarter to September 2026, against a year earlier

167.46 7.02 −4.02%

Follow GILD

Alert me

Market cap: $207.8B
P/E: 0.0×
Fwd P/E: −41.3×
Dividend yield: 1.94%
F-score: 8/9
Altman Z: 4.03
Beneish M: −2.45
Dividend safety: 77/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Gilead Sciences, Inc. (GILD) P/E ratio

Alert me on P/E ratio

Gilead Sciences, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 979× (November 2024) — the current reading is the lowest in ten years.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/GILD/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Gilead Sciences, Inc. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/GILD/metrics/pe-ratio">Gilead Sciences, Inc. (GILD) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	17.9×	(92.63%)
FY2024	243×	1,228.70%
FY2023	18.3×	(21.37%)
FY2022	23.3×	58.62%
FY2021	14.7×	(97.48%)
FY2020	583×	3,701.51%
FY2019	15.3×	2.90%
FY2018	14.9×	(28.85%)
FY2017	20.9×	184.52%
FY2016	7.4×	(10.14%)

Period	P/E ratio	Change
Sep 2026	0.0×	—
Jun 2026	0.0×	—
Mar 2026	18.8×	4.83%
Dec 2025	17.9×	5.25%
43 more quarters	Free account

Against its own ten years

Low 0.0× High 979×

Ten-year median 17.3×

Current reading's percentile 5

Company	P/E ratio
GILD Gilead Sciences, Inc.	n/m
NVO Novo Nordisk A/S compare	9.9×
BMY Bristol Myers Squibb Company compare	14.0×
SNY Sanofi compare	23.2×
AZN AstraZeneca PLC compare	26.3×
AMGN Amgen Inc. compare	26.6×
NVS Novartis AG compare	30.9×
PFE Pfizer Inc. compare	42.2×
MRK Merck & Co., Inc. compare	118×
Drug Manufacturers General industry median	26.6×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Gilead Sciences, Inc. (GILD) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on GILD

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on GILD

Stockrow Weekly